宜宾开眼角恢复期(宜宾纹眉眼线哪里好) (今日更新中)

CARACAS, March 30 (Xinhua) -- The number of confirmed cases of the A/H1N1 influenza in Venezuela has risen to 482 this year, Health Minister Eugenia Sader said on Wednesday.According to the latest report, the state of Merida in southeastern Venezuela has 189 A/H1N1 influenza cases, the biggest number ever reported, which was followed by the Capital District of Caracas with 112 cases. The other 181 cases were confirmed in 17 of 24 Venezuelan states.The first case for this year was reported in Merida earlier this month.Sader said that the Venezuelan government was trying to prevent the spread of the disease. Some 3 million people have been vaccinated against the virus.Three patients infected with the A/H1N1 influenza virus have died in the country this year, according to Sader.The A/H1N1 influenza can cause deadly pneumonia if it is not treated early.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

LOS ANGELES, March 4 (Xinhua) -- The California Department of Public Health on Friday announced a recall of hazelnuts which might be contaminated by E. coli bacteria.The department said it ordered the recall after seven people fell sick with E. coli bacteria from eating tainted hazelnuts.The seven illnesses include one in Michigan, three in Minnesota and three in Wisconsin, said Dr. Howard Backer, interim director of the department.The hazelnuts were distributed by DeFranco & Sons, a Los Angeles company, said the department.After being notified of the contamination, the company is voluntarily recalling the nuts, the department said.The hazelnuts affected by the recall were sold under the brand names Sunripe, George Packing, Firestone Farms and Northwest Hazelnut and were distributed nationwide from Nov. 2 to Dec. 22, according to the department.The 50-pound bags of hazelnuts and mixed nuts with hazelnuts may have been repacked or sold from bulk containers, the department said, adding people who had bought the hazelnuts should not eat them.Consumers should check with retailers to determine if their nuts are subject to the recall, and if they are, should discard them, the department added.People who develop symptoms after consuming hazelnuts should seek immediate medical attention, the department suggested.E. coli may cause symptoms that include bloody diarrhea, stomach cramps and dehydration. In extreme cases, patients can suffer potentially life-threatening complication known as hemolytic uremic syndrome, which includes kidney failure.Young children and the elderly are the most vulnerable to the risk.

BEIJING, May 12 (Xinhuanet) -- Italian archaeologists are digging the remains of Lisa Gherardini, a 16th-century woman who is widely believed to be the model for the famous portrait Mona Lisa, AFP reported on Wednesday.The team of historians say they will try to find the remains using geo-radar equipment and then try to re-create a likeness of what the woman, Lisa Gherardini, would have looked like to compare her to Leonardo Da Vinci's Mona Lisa.Gherardini (1479-1542), also known by her married name as Lisa del Giocondo, was the wife of a Florentine silk merchant and is widely believed to have been the model for the  portrait that now hangs in the Louvre in Paris.But the issue has never been settled definitively and mystery still shrouds the model's enigmatic expression and other details of the portrait.

LOS ANGELES, April 7 (Xinhua) -- Using NASA's Galaxy Evolution Explorer (GEE) satellite, U.S. astronomers are hunting for nearby, hard-to-see stars which could very well be home to the easiest-to-see alien planets, it was announced on Thursday.U.S. astronomers are ferreting out the new targets after the glare of bright, shining stars has frustrated most efforts at visualizing distant worlds, NASA's Jet Propulsion Laboratory (JPL) said.So far, only a handful of distant planets, or exoplanets, have been directly imaged. Small, newborn stars are less blinding, making the planets easier to see, but the fact that these stars are dim means they are hard to find in the first place."Fortunately, the young stars emit more ultraviolet light than their older counterparts, which makes them conspicuous to the ultraviolet-detecting GEE," JPL said in a press release."We've discovered a new technique of using ultraviolet light to search for young, low-mass stars near the Earth," said David Rodriguez, a graduate student of astronomy at University of Californian, Los Angeles. "These young stars make excellent targets for future direct imaging of exoplanets."Young stars, like human children, tend to be a bit unruly -- they spout a greater proportion of energetic X-rays and ultraviolet light than more mature stars. In some cases, X-ray surveys can pick out these youngsters due to the "racket" they cause. However, many smaller, less "noisy" baby stars perfect for exoplanet imaging studies have gone undetected except in the most detailed X-ray surveys. To date, such surveys have covered only a small percentage of the sky, according to JPL in Pasadena, Los Angeles.Rodriguez and his team figured that the GEE, which has scanned about three-quarters of the sky in ultraviolet light, could fill this gap.Astronomers compared readings from the telescope with optical and infrared data to look for the telltale signature of rambunctious junior stars. Follow-up observations of 24 candidates identified in this manner determined that 17 of the stars showed clear signs of youth, validating the team's approach, JPL said."The Galaxy Evolution Explorer can readily select young, low- mass stars that are too faint to turn up in all-sky X-ray surveys, which makes the telescope an incredibly useful tool," Rodriguez said in the release.

来源：资阳报